Skip to content

Anorectal Manometry of Patients With Constipation Predominant IBS

Anorectal Manometry of Patients With Constipation Predominant Irritable Bowel Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05921383
Enrollment
102
Registered
2023-06-27
Start date
2023-07-01
Completion date
2025-12-31
Last updated
2023-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation-predominant Irritable Bowel Syndrome

Brief summary

The aim of The study is to compare between the anorectal manometric profile of patients with functional constipation and patients with constipation predominant irritabe bowel syndrome

Detailed description

Chronic constipation (CC) is a common medical problem throughout the world \[1-3\] The global prevalence of CC in the community varies from 11% to 18% \[4\]. In patients presenting to tertiary care facilities, specific pathophysiological abnormalities like defecatory disorder and slow colonic transit contribute to CC. CC has a significant burden on the utilization of healthcare resources, including the cost of inpatient and outpatient care, laboratory tests, and diagnostic procedures \[5, 6\]. CC is characterized by difficulty in passing stools or a low frequency of bowel movements, often accompanied by straining during defecation or a feeling of incomplete evacuation \[7, 8\]. For western population, CC is defined by Bristol stool form (BSF) I-II, while in Indian patients, addition of type III Bristol stool form increases diagnostic sensitivity \[2\]. In the ROME IV criteria, it has been suggested that all patients with CC without evidence of structural or metabolic abnormalities to explain symptoms should be considered under the umbrella of functional constipation (FC) \[8\]. FC is defined as the presence of two or more of the followings during the previous 3 months: 1. Defecatory straining (\> 25% of bowel movements) 2. Hard or lumpy stools (\> 25% of bowel movements) 3. Feeling of incomplete evacuation (\> 25% of bowel movements) 4. Defecatory obstruction (\> 25% of bowel movements) 5. Manual maneuvers to facilitate defecation (\> 25% of bowel movements) 6. Fewer than three spontaneous complete bowel movements per week. Symptoms must be present for at least 6 months before the diagnosis, and diarrhea must not be present except after using a laxative \[8\]. Patients with FC should not meet irritable bowel syndrome (IBS) criteria, although bloating may be present. In contrast, patients with irritable bowel syndrome with constipation (IBS-C) have abdominal pain as the predominant symptom along with Bristol stool form types 1 or 2 more than 25% of the times. \[8\]. Among patients presenting with CC, Indian studies have reported FC to be commoner than IBS-C \[9, 10-12\]. High-resolution (HR-) anorectal manometry has significant diagnostic value in the assessment of anorectal disorders \[13\] This study aimed to compare the clinical and anorectal manometry profile of patients with FC and constipation-predominant irritable bowel syndrome

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years

Inclusion criteria

1. Age between 18- 60 years old . 2. Patients fulfill ROME IV criteria of chronic constipation.

Exclusion criteria

* Patient with secondary causes of constipation :- 1. Thyroid disease 2. Acute or chronic kidney disease 3. Acute or Chronic Liver Disease. 4. Malignancy 5 -Medication 6 -Uncontrolled diabetes mellitus 7 -Inflammatory bowel diseases

Design outcomes

Primary

MeasureTime frameDescription
Value of manometry for diagnosis of functional constipation1yearsThe aim of The study is to compare between the anorectal manometric profile of patients with functional constipation and patients with constipation predominant irritabe bowel syndrome

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026